1. Home
  2. FCCO vs ALLO Comparison

FCCO vs ALLO Comparison

Compare FCCO & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$28.90

Market Cap

228.0M

Sector

Finance

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.79

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCCO
ALLO
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.0M
252.9M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
FCCO
ALLO
Price
$28.90
$2.79
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$8.27
AVG Volume (30 Days)
54.4K
6.0M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
2.13%
N/A
EPS Growth
16.77
36.84
EPS
1.85
N/A
Revenue
$952,000.00
$22,000.00
Revenue This Year
$30.67
N/A
Revenue Next Year
$5.87
N/A
P/E Ratio
$16.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.46
$0.86
52 Week High
$31.50
$2.73

Technical Indicators

Market Signals
Indicator
FCCO
ALLO
Relative Strength Index (RSI) 39.63 76.59
Support Level $26.32 $1.01
Resistance Level $29.73 N/A
Average True Range (ATR) 0.79 0.19
MACD -0.13 0.09
Stochastic Oscillator 6.55 97.57

Price Performance

Historical Comparison
FCCO
ALLO

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: